FLT3/NPM1 test | Genomic Diagnostics

Test description

Mutations in the FLT3 and NPM1 genes are seen in acute myeloid leukaemia (particularly in cases with a normal cytogenetic karyotype) and are of prognostic significance.

Test information

Test name

Nucleophosmin & FLT3

Clinical indication

For diagnosis, prognosis, and classification in acute myeloid leukaemia

Gene(s)

NPM1, FLT3

Method

Real-time PCR analysis; Conventional PCR and capillary electrophoresis

Turn around time

2 weeks

Medicare eligibility

73314

Price

If not MBS eligible please contact 1800 822 999 for details

Test request form

Standard pathology request form

Sample type

6mL Blood EDTA tube or 1 mL bone marrow EDTA tube

Collection type

Blood or bone marrow

Special instructions

Test is performed on either peripheral blood or bone marrow aspirate. Peripheral blood can be collected by a collector, bone marrow aspirate (doctor collect only) must be placed into EDTA.